Navigation Links
Apelon Announces Availability of New TermManager® Software
Date:10/24/2011

RIDGEFIELD, Conn., Oct. 24, 2011 /PRNewswire/ -- Apelon, Inc., a leading provider of terminology and data interoperability solutions, today announced the availability of the first comprehensive, cloud-based terminology mapping solution. TermManager, a code set management and collaborative mapping application, cost-effectively supports healthcare data interoperability initiatives by enabling widespread access to national healthcare vocabulary standards including SNOMED CT®, LOINC®, ICD, RxNorm and NDF-RT. Using TermManager, individuals and organizations can map legacy information to required standards for Meaningful Use incentive payments, departmental data consolidation and regional integration. TermManager is today's answer to the mission-critical data interoperability needs of health systems.

Easy to use, TermManager is a virtual application that can be accessed by anyone with a web browser to manage sets of local terms and map them to national data standards. For instance, a lab manager can map local laboratory test names to LOINC concepts, or a medical records specialist can map their problem list to SNOMED CT. No infrastructure purchase is required, and flexible licensing terms are available facilitating widespread adoption and encouraging greater use of mapping for terminology normalization.

"Mapping local terms to national and international standards is a fundamental requirement for healthcare data to be comparable and interoperable," said Stephen Coady, Apelon's President and CEO.  "By innovating the distribution model for TermManager, Apelon is further supporting the needs of data standardization and interoperability in Electronic Medical Records systems and Healthcare Information Exchanges. TermManager will enable Accountable Care Organizations, hospitals, laboratories, EMR vendors and decision support companies alike, to standardize and manage their data sets, leading to more accurate and comparable reporting, identification of best proven practices and reduction of practice variation."

TermManager maintains local code sets and the latest versions of industry standard code systems, including Meaningful Use subsets, in a secure infrastructure with around-the-clock access by registered users. Accurate, up-to-date mappings are assured through the use of Apelon's proven TermWorks matching technology, and role-based access control is available with flexible workflow processes for review and approval.  An additional product differentiator is the unique capability for users to view map results made by other members of the TermManager community, further enhancing learning and increasing map development efficiency.

For further information about TermManager, visit www.Apelon.com/TermManager

About Apelon

Apelon is an international clinical informatics company focusing on data standardization and interoperability. Apelon software and professional services helps leading healthcare enterprises, life sciences organizations and government agencies improve the quality, comparability and accessibility of their information.  Visit www.Apelon.com for additional information.

TermManager is a registered trademark of Apelon, Inc.


'/>"/>
SOURCE Apelon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, today announced the ... the New Animal Drug Application (NADA) for Zimeta™ (dipyrone ... study (KB0120) of Zimeta for the control of pyrexia ... --> --> The ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises ... businesses. , The increasingly modern world of instantaneous consumption proves very convenient for ... sources such as oil and coal, which pollutes our air, water, and soil. It ...
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or “honeymoon” stage of ... perfection, go out of their way to be romantic, and may exaggerate a strength ... at any online dating profile. , A recent study from Queendom.com , ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology ... for the ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards ... Executive Forum and Awards Gala on March 15, 2016 at the Westin Peachtree ...
Breaking Medicine News(10 mins):